Of the two different forms of Betoptic (betaxolol), only one is available as a generic. It is sold under the name Betaxolol Hydrochloride 0.5% solution. This product is considered equivalent to the brand-name eye drop.
Betoptic® (betaxolol hydrochloride) is a prescription eye drop approved for the treatment of glaucoma and high eye pressure. Betoptic belongs to a group of medications known as beta blockers. This medicine comes in two different forms -- regular Betoptic (a solution) and Betoptic S® (a suspension). In a solution, the medication is dissolved in the liquid and does not need to be shaken; in a suspension, the medication is not dissolved and must be shaken well before each dose.
Brand-name Betoptic products are made by Alcon Laboratories. While regular Betoptic is available in generic form, there are no generic versions of Betoptic S at this time.
Although the patents for both Betoptic products have expired, the United States Food and Drug Administration (FDA) granted manufacturers of Betoptic S an additional exclusivity period (during which no generic versions are allowed) for performing much-needed studies of the medication in children. That exclusivity period for Betoptic S expired in December 2010. However, no generic versions have yet been approved. It is difficult to predict when (or even if) generic versions of Betoptic S may become available.
Although Betoptic S suspension is not available in generic form, regular Betoptic solution is available as a generic (sold as "Betaxolol Hydrochloride 0.5 percent solution"). A few different companies make this generic version of Betoptic, including:
- Bausch & Lomb
- Falcon Pharmaceuticals.